Curio, S., Jonsson, G. & Marinović, S. (2021). A summary of current NKG2D-based CAR clinical trials. Immunotherapy Advances, 1. (1), 1-8. doi: 10.1093/immadv/ltab018
Curio, Sophie, et al. "A summary of current NKG2D-based CAR clinical trials." Immunotherapy Advances, vol. 1, no. 1, 2021, pp. 1-8. https://doi.org/10.1093/immadv/ltab018
Curio, Sophie, Gustav Jonsson and Sonja Marinović. "A summary of current NKG2D-based CAR clinical trials." Immunotherapy Advances 1, no. 1 (2021): 1-8. https://doi.org/10.1093/immadv/ltab018
Curio, S., Jonsson, G. and Marinović, S. (2021) 'A summary of current NKG2D-based CAR clinical trials', Immunotherapy Advances, 1(1), pp. 1-8. doi: 10.1093/immadv/ltab018
Curio S, Jonsson G, Marinović S. A summary of current NKG2D-based CAR clinical trials. Immunotherapy Advances [Internet]. 2021 January 01 [cited 2024 September 10];1(1):1-8. doi: 10.1093/immadv/ltab018
S. Curio, G. Jonsson and S. Marinović, "A summary of current NKG2D-based CAR clinical trials", Immunotherapy Advances, vol. 1, no. 1, pp. 1-8, January 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:286089. [Accessed: 10 September 2024]